03 / Co-founded

Carez AI

Synthetic medical imaging for training and validating AI systems. Grew to a five-person team and $500K+ ARR.

MY ROLE
Co-founder · product, GTM, demos & pilots
CONTEXT
Company project · existing portfolio visual
  • Synthetic imaging
  • Dataset design
  • Model evaluation
Carez AIData designer
Existing Carez AI portfolio visual showing annotated and unannotated image datasets, edge cases, and training options
Existing portfolio visual · Carez AI

01The problem

Medical AI development depends on suitable data for training and validation. Carez AI focuses on synthetic medical image datasets, including annotated data and edge cases.

The existing data-designer visual organizes datasets by annotation status, edge cases, and new device or clinic scenarios.

Evidence to addAdd an approved customer problem or pilot brief to show which data gap mattered in practice.

02What I owned

I co-founded Carez AI, grew the team to five people, and scaled the company to $500K+ ARR.

My existing portfolio records ownership of product, GTM, demos, pilots, and pricing. The model engineering and infrastructure contributions need a more precise individual-versus-team breakdown.

Evidence to addAdd one product artifact personally authored and identify the collaborators behind the technical implementation.

03Product decisions

The existing visual separates annotated and unannotated datasets and surfaces edge cases alongside new device or clinic scenarios. Those are visible product choices; the reasoning behind them has not yet been documented here.

Evidence to addExplain one real prioritization decision: which customer workflow came first, what was deferred, and why.

04Technical approach

  • Synthetic medical image datasets for AI training and validation.
  • Dataset organization around annotations and edge cases.
  • A data-designer interface with generation and evaluation workflows.

The model architectures, training framework, backend, and cloud stack are not yet confirmed for this case study.

Evidence to addAdd the actual stack and an approved evaluation method. Do not include patient data or unapproved clinical claims.

05What shipped

A synthetic medical imaging platform, with product demos and pilot work described in the existing portfolio. The data-designer visual shows the product surface; it is not a release record.

Evidence to addAdd a dated product walkthrough or approved pilot deliverable to document what reached users.

06Outcomes & lessons

Five-person team. $500K+ ARR. These are the company milestones supplied for this portfolio.

They establish business progress, not model quality or clinical performance.

Evidence to addAdd a shareable source for the milestones and one concrete lesson from a pilot, customer conversation, or pricing decision.